JPWO2022120217A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022120217A5
JPWO2022120217A5 JP2023534100A JP2023534100A JPWO2022120217A5 JP WO2022120217 A5 JPWO2022120217 A5 JP WO2022120217A5 JP 2023534100 A JP2023534100 A JP 2023534100A JP 2023534100 A JP2023534100 A JP 2023534100A JP WO2022120217 A5 JPWO2022120217 A5 JP WO2022120217A5
Authority
JP
Japan
Prior art keywords
nucleic acid
sequence
epitope
encoding nucleic
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023534100A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023553014A (ja
JP2023553014A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/061876 external-priority patent/WO2022120217A2/en
Publication of JP2023553014A publication Critical patent/JP2023553014A/ja
Publication of JPWO2022120217A5 publication Critical patent/JPWO2022120217A5/ja
Publication of JP2023553014A5 publication Critical patent/JP2023553014A5/ja
Pending legal-status Critical Current

Links

JP2023534100A 2020-12-03 2021-12-03 同種アデノウイルスワクチン接種の方法 Pending JP2023553014A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063121164P 2020-12-03 2020-12-03
US63/121,164 2020-12-03
PCT/US2021/061876 WO2022120217A2 (en) 2020-12-03 2021-12-03 Homologous adenoviral vaccination

Publications (3)

Publication Number Publication Date
JP2023553014A JP2023553014A (ja) 2023-12-20
JPWO2022120217A5 true JPWO2022120217A5 (https=) 2024-12-10
JP2023553014A5 JP2023553014A5 (https=) 2024-12-10

Family

ID=81854908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023534100A Pending JP2023553014A (ja) 2020-12-03 2021-12-03 同種アデノウイルスワクチン接種の方法

Country Status (9)

Country Link
US (1) US20240093235A1 (https=)
EP (1) EP4255477A4 (https=)
JP (1) JP2023553014A (https=)
KR (1) KR20230117163A (https=)
CN (1) CN116669760A (https=)
AU (1) AU2021391921A1 (https=)
CA (1) CA3200935A1 (https=)
IL (1) IL303298A (https=)
WO (1) WO2022120217A2 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040136963A1 (en) * 2001-06-22 2004-07-15 The Trustees Of The University Of Pennsylvania Simian adenovirus vectors and methods of use
CN112368386A (zh) * 2018-05-23 2021-02-12 磨石肿瘤生物技术公司 共有抗原
BR112021010611A2 (pt) * 2018-12-14 2021-08-24 Glaxosmithkline Biologicals S.A. Composições e métodos de vacina de reforço (prime boost) heterólogo
WO2021092095A1 (en) * 2019-11-04 2021-05-14 Gritstone Oncology, Inc. Neoantigen vaccine therapy

Similar Documents

Publication Publication Date Title
JP2021525076A5 (https=)
JPWO2019226941A5 (https=)
JP2021524247A5 (https=)
JP7554119B2 (ja) 共有抗原
RU2019119272A (ru) Вирусная доставка неоантигенов
JP2021524247A (ja) 免疫チェックポイント阻害剤の共発現ベクター
US20220125919A1 (en) Alphavirus neoantigen vectors and interferon inhibitors
TW201907937A (zh) 阿爾法病毒新抗原載體
CN111630060A (zh) 用于在疾病的预防和/或治疗中使用的疫苗
FI3652606T3 (fi) Jaettuihin tuumorineoantigeeneihin perustuva yleisrokote epästabiilien mikrosatelliitti (msi) -syöpien ennaltaehkäisyyn ja hoitoon
JPWO2021236854A5 (https=)
CN115397838A (zh) 溶瘤病毒样囊泡的组合物和使用方法
JP2020532287A (ja) 癌の治療のためのネオアンチゲンワクチン組成物
JPWO2019226939A5 (https=)
JPWO2020097393A5 (https=)
CN115942942A (zh) 感染性疾病抗原和疫苗
JPWO2022032196A5 (https=)
JPWO2020243719A5 (https=)
CA3170843A1 (en) Neoantigens expressed in multiple myeloma and their uses
JPWO2021003348A5 (https=)
JPWO2021216776A5 (https=)
JPWO2021203104A5 (https=)
JPWO2022120217A5 (https=)
JPWO2021216775A5 (https=)
KR20240099144A (ko) 신생항원 보조 및 유지 요법